Skip to content

Role Of Individualized Homoeopathic Medicine In The Treatment Of Seborrheic Dermatitis in age group of 5-50years

Effectiveness Of Individualized Homoeopathic Medicine In The Treatment Of Seborrheic Dermatitis In Age Group Of 5-50 Years - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081542
Enrollment
34
Registered
2025-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L219- Seborrheic dermatitis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Individualized Homoeopathic Medicine Medicine will be administered in the form of globules and powder through oral route. Further doses will be adm

Sponsors

Dr Divya Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects suffering from seborrheic dermatitis for 1 year or longer. 2.Subjects in age group of 5-50 years of both sexes. 3.Subjects already undergoing regular oral/topical conventional therapy for seborrheic dermatitis may be recruited only if the medications are stopped completely 3 months prior to the treatment.

Exclusion criteria

Exclusion criteria: 1.Subjects under the treatment of any other therapy. 2.Subjects having another serious chronic disease. 3.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life threating illness.

Design outcomes

Primary

MeasureTime frame
To study the effectiveness of individualized homoeopathic medicine in the treatment of seborrheic dermatitis in age group of 5 - 50 years.Timepoint: Role of individualized homoeopathic medicine in the treatment of seborrheic dermatitis in age group of 5 - 50 years.

Secondary

MeasureTime frame
1.To assess the effectiveness of individualized homoeopathic medicine in the treatment of seborrheic dermatitis. 2.To assess the improvement of patient in seborrheic dermatitis by comparing the changes in POSCORAD score before and after the treatment 3.To improve quality of life of patient by reducing seborrheic dermatitis and improving the overall skin conditions.Timepoint: Score of the POSCORAD index will be calculated at the time of enrollment of patient and at the end of last follow ups.The score of DLQI questionnaire will be calculated at the time of enrollment of patient and at every 15 days of follow ups for 6 months.

Countries

India

Contacts

Public ContactDr Sushma Suresh Manhas

B.V.D.U. Homoeopathic Medical College and Hospital, Dept of Post Graduate and Research Centre, Pune

sushma.manhas@bharatividyapeeth.edu9822322533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026